High-concentration 8% capsaicin patches (179 mg) were first licensed in the United States in 2009 and are approved by the U.S. Food and Drug Administration for neuropathic pain associated with postherpetic neuralgia or diabetic peripheral neuropathy of the feet. In oncology settings, capsaicin has been used off label to treat chemotherapy-induced peripheral neuropathy and postsurgical neuropathic pain (e.g., mastectomy, melanoma surgery).
I use Aspercreme with Lidocaine. It works lots better than Nervive for me, or anything else I have tried.
I do too!
Can capsaicin patches help with chemotherapy-induced neuropathy from breast cancer treatment?
Yes, capsaicin patches can be used to help manage nerve pain from breast cancer treatment. While high-concentration capsaicin patches are FDA-approved for other types of nerve pain, they're sometimes used off-label for Show Full Answer